Purpose: Family conferences are used to facilitate communication concerning end-of-life issues with patients and their families. The purpose of our study was to obtain preliminary information on the characteristics of family conferences that take place in an inpatient palliative care unit (PCU).
Methods: A retrospective chart review was conducted during a 6-month period that identified 123 documented family conferences. Data including demographic information, type of cancer, and discharge disposition were collected. Timing, number of participants, expressions of emotional distress, conflict with health care providers, and topics discussed during the conference were collected.
Results: Sixty-one patients (50%) were female, 75 (61%) were white, 95 (77%) had solid tumors. Median age of patients was 61. In 74 of the 123 documented family meetings (60%), patients actively participated. Family conferences took place a median of 3 days prior to discharge. During the meetings, questions concerning advanced directives and withdrawal of care were found to be infrequent. Eighteen percent of patients expressed emotional distress, while 40% of families expressed distress which was higher at 47% when the patient was not present.
Conclusions: Family conferences involved a high degree of patient participation and occurred at the end of a patients stay in our PCU. A trend toward greater expression of emotional distress displayed by family members was found when patients did not participate in the meetings. Further prospective studies that use validated tools to assess the content of the meetings and their impact on alleviating distress in patients and their family are needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1089/jpm.2008.0150 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Case Management Does Matter.
Prof Case Manag
January 2025
Lynn S. Muller, JD, RN, BA-HCM, CCM, began her career at Pace University as a Registered Professional Nurse (RN), went onto earn her Bachelor of Arts Degree in Health Care Management at St. Peter's University of New Jersey and then her Juris Doctor from Quinnipiac University School of Law. She is currently a practicing Attorney and the managing partner of Muller & Muller. Her practice includes the defense of healthcare professionals before the state licensing boards, case management litigation, family law, wills, trusts, and estates, as well as consulting representation of medical practitioners, facilities and health service corporations on such issues as regulatory compliance and day-to-day operations. Dr. Muller is a popular and sought-after keynote and session speaker at national and regional conferences. She is the Contributing Editor of Professional Case Management: The Official Journal of the Case Management Society of America (CMSA), She is a former member of the Board of Directors of CMSA of New York City and a former adjunct Professor at Saint Peter's University School of Nursing in the MSN and DNP Programs. Dr. Muller is the author of over 80 articles in nursing and case management journals and listed on the NIH website. She is a contributor to the 2016 CMSA Standards of Practice and CMSA Career & Knowledge Pathways. Dr. Muller is the author of both legal chapters of the 3rd edition of Case Management: A Practical Guide for Education and Practice and 3rd edition of the CMSA Core Curriculum for Case Management. She is a former Commissioner for the Commission for Case Management Certification (CCMC), where she now serves on the Professional Development and Education Committee, is a Certified Facilitator for CCM CERTIFCATION 360™ a Multi-day Immersion Program and other special projects. She is a contributor to the CCMC Case Management Body of Knowledge (CMBOK) and a past President of the New Jersey Chapter of CMSA. Dr. Muller is the former Director of Social Services for the Borough of Bergenfield, N.J., a community-based case management program she developed and initiated. Dr. Muller has also served her community as public defender, municipal court judge, councilwoman and chaired the Borough's Barrier Free Committee.
Meaningful Medication Reconciliation.
Prof Case Manag
January 2025
Lynn S. Muller, JD, RN, BA-HCM, CCM, began her career at Pace University as a Registered Professional Nurse (RN), went onto earn her Bachelor of Arts Degree in Health Care Management at St. Peter's University of New Jersey and then her Juris Doctor from Quinnipiac University School of Law. She is currently a practicing Attorney and the managing partner of Muller & Muller. Her practice includes the defense of healthcare professionals before the state licensing boards, case management litigation, family law, wills, trusts, and estates, as well as consulting representation of medical practitioners, facilities and health service corporations on such issues as regulatory compliance and day-to-day operations. She is a popular and sought-after keynote and session speaker at national and regional conferences. She is the Contributing Editor of Professional Case Management: The Official Journal of the Case Management Society of America (CMSA), She is a former member of the Board of Directors of CMSA of New York City and a former adjunct Professor at Saint Peter's University School of Nursing in the MSN and DNP Programs. She is the author of over 80 articles in nursing and case management journals and listed on the NIH website. She is a contributor to the 2016 CMSA Standards of Practice and CMSA Career & Knowledge Pathways. She is the author of both legal chapters of the 3rd edition of Case Management: A Practical Guide for Education and Practice and 3rd edition of the CMSA Core Curriculum for Case Management. She is a former Commissioner for the Commission for Case Management Certification (CCMC), where she now serves on the Professional Development and Education Committee, is a Certified Facilitator for CCM CERTIFCATION 360 a Multi-day Immersion Program and other special projects. She is a contributor to the CCMC Case Management Body of Knowledge (CMBOK) and a past President of the New Jersey Chapter of CMSA. She is the former Director of Social Services for the Borough of Bergenfield, NJ, a community-based case management program she developed and initiated. She has also served her community as public defender, municipal court judge, councilwoman and chaired the Borough's Barrier Free Committee.
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial.
Lancet Neurol
February 2025
Department of Clinical Neurological Sciences, University of Western Ontario, London, ON, Canada; Department of Cognitive Neurology, St Joseph's Health Care London, London, ON, Canada. Electronic address:
Background: No treatments exist for apathy in people with frontotemporal dementia. Previously, in a randomised double-blind, placebo-controlled, dose-finding study, intranasal oxytocin administration in people with frontotemporal dementia improved apathy ratings on the Neuropsychiatric Inventory over 1 week and, in a randomised, double-blind, placebo-controlled, crossover study, a single dose of 72 IU oxytocin increased blood-oxygen-level-dependent signal in limbic brain regions. We aimed to determine whether longer treatment with oxytocin improves apathy in people with frontotemporal dementia.
View Article and Find Full Text PDFIntroduction: Access to care varies by sociodemographic group, with some groups facing higher barriers to care than others. This study will use novel methods to explore barriers and potential solutions as perceived by members of the population groups who are least able to access care. We aim to use rapid yet robust mixed methods that allow us to identify generalisable findings within each programme and testable service modifications to improve equitable access to care; delivering non-tokenistic findings within a matter of weeks.
View Article and Find Full Text PDFEthics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.
Wellcome Open Res
December 2024
National University of Singapore, Singapore, Singapore.
Unlabelled: Since the inception of transplantation, it has been crucial to ensure that organ or tissue donations are made with valid informed consent to avoid concerns about coercion or exploitation. This issue is particularly challenging when it comes to infants and younger children, insofar as they are unable to provide consent. Despite their vulnerability, infants' organs and tissues are considered valuable for biomedical purposes due to their size and unique properties.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!